FOR IMMEDIATE RELEASE
PALADIN LABS ANNOUNCES FOURTH QUARTER AND YEAR-END RESULTS CONFERENCE CALL
Montreal, Canada, February 4, 2003 - Paladin Labs Inc. (TSX: PLB), a Canadian specialty pharmaceutical company focused on marketing and selling urology, endocrinology and women’s health products, today announced it will release its financial results for the fourth quarter and year ended December 31, 2002 on Thursday, February 6, 2003 prior to market opening. Following the release, Paladin will host a conference call at 11:00 a.m. (EST) to discuss its results. Paladin cordially invites all interested parties to participate in this call.
DATE: Thursday, February 6, 2003 TIME: 11:00 a.m. EST DIAL IN NUMBER: 1-877-295-2825 or 416-405-8532 REFERENCE NUMBER: 1368541 TAPED REPLAY: 1-800-408-3053 OR 416-695-5800
Available from Thursday, February 6th at 1:00 p.m. until
Thursday, February 13th at midnight.The call will be hosted by Mr. Jonathan Ross Goodman, President and CEO of Paladin Labs, and will be followed by a question and answer period.
The call will also be audio-cast live and archived for 90 days at www.paladinlabs.com and www.financialdisclosure.ca.
About Paladin Labs Inc.
Paladin Labs Inc., headquartered in Montreal, Quebec, is a rapidly growing pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada’s leading specialty pharmaceutical companies. Paladin’s shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Paladin web site at www.paladinlabs.com
For further information please contact:Paladin Labs Inc.
Samira Sakhia, Chief Financial Officer
Tel: 514-340-5067
e-mail: info@paladin-labs.com
Web Site: www.paladinlabs.comThe Equicom Group Inc.
Bruce Wigle
Investor Relations
Tel: 416-815-0700 ext.228
e-mail: bwigle@equicomgroup.com